State Street’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $189M | Buy |
3,982,500
+229,060
| +6% | +$12.1M | 0.01% | 970 |
|
|
2025
Q4 | $197M | Sell |
3,753,440
-253,793
| -6% | -$15.2M | 0.01% | 942 |
|
|
2025
Q3 | $260M | Buy |
4,007,233
+736,637
| +23% | +$42.3M | 0.01% | 800 |
|
|
2025
Q2 | $159M | Buy |
3,270,596
+859,334
| +36% | +$33.3M | 0.01% | 1048 |
|
|
2025
Q1 | $82.1M | Sell |
2,411,262
-80,263
| -3% | -$3.4M | ﹤0.01% | 1381 |
|
|
2024
Q4 | $98.1M | Sell |
2,491,525
-501,463
| -17% | -$23.7M | ﹤0.01% | 1345 |
|
|
2024
Q3 | $141M | Buy |
2,992,988
+599,304
| +25% | +$30.4M | 0.01% | 1124 |
|
|
2024
Q2 | $129M | Buy |
2,393,684
+898,476
| +60% | +$52M | 0.01% | 1106 |
|
|
2024
Q1 | $102M | Sell |
1,495,208
-258,289
| -15% | -$18.5M | ﹤0.01% | 1292 |
|
|
2023
Q4 | $110M | Sell |
1,753,497
-131,476
| -7% | -$7.27M | 0.01% | 1233 |
|
|
2023
Q3 | $85.6M | Buy |
1,884,973
+252,500
| +15% | +$13M | ﹤0.01% | 1286 |
|
|
2023
Q2 | $91.6M | Sell |
1,632,473
-353,714
| -18% | -$20.1M | ﹤0.01% | 1281 |
|
|
2023
Q1 | $89.8M | Sell |
1,986,187
-94,929
| -5% | -$4.61M | 0.01% | 1258 |
|
|
2022
Q4 | $84.6M | Buy |
2,081,116
+512,732
| +33% | +$27.2M | 0.01% | 1274 |
|
|
2022
Q3 | $102M | Sell |
1,568,384
-1,476
| -0.1% | -$107K | 0.01% | 1095 |
|
|
2022
Q2 | $95.4M | Buy |
1,569,860
+1,092,384
| +229% | +$64.2M | 0.01% | 1186 |
|
|
2022
Q1 | $30M | Buy |
477,476
+269,824
| +130% | +$16.9M | ﹤0.01% | 2109 |
|
|
2021
Q4 | $15.7M | Buy |
207,652
+45,010
| +28% | +$3.93M | ﹤0.01% | 2643 |
|
|
2021
Q3 | $18.2M | Buy |
162,642
+11,726
| +8% | +$1.47M | ﹤0.01% | 2540 |
|
|
2021
Q2 | $24.4M | Buy |
150,916
+1,661
| +1% | +$202K | ﹤0.01% | 2388 |
|
|
2021
Q1 | $18.2M | Buy |
149,255
+13,894
| +10% | +$2.1M | ﹤0.01% | 2416 |
|
|
2020
Q4 | $20.7M | Sell |
135,361
-5,950
| -4% | -$703K | ﹤0.01% | 2222 |
|
|
2020
Q3 | $11.8M | Buy |
141,311
+20,522
| +17% | +$1.82M | ﹤0.01% | 2352 |
|
|
2020
Q2 | $8.88M | Buy |
120,789
+49,578
| +70% | +$2.9M | ﹤0.01% | 2486 |
|
|
2020
Q1 | $3.02M | Buy |
71,211
+23,159
| +48% | +$1.2M | ﹤0.01% | 2870 |
|
|
2019
Q4 | $2.93M | Buy |
48,052
+10,949
| +30% | +$598K | ﹤0.01% | 3101 |
|
|
2019
Q3 | $1.52M | Buy |
37,103
+758
| +2% | +$36.2K | ﹤0.01% | 3300 |
|
|
2019
Q2 | $1.71M | Buy |
36,345
+10,292
| +40% | +$411K | ﹤0.01% | 3295 |
|
|
2019
Q1 | $931K | Sell |
26,053
-300
| -1% | -$10.4K | ﹤0.01% | 3349 |
|
|
2018
Q4 | $753K | Sell |
26,353
-1,117
| -4% | -$38.8K | ﹤0.01% | 3381 |
|
|
2018
Q3 | $1.22M | Buy |
27,470
+3,337
| +14% | +$175K | ﹤0.01% | 3375 |
|
|
2018
Q2 | $1.42M | Buy |
+24,133
| New | +$1.37M | ﹤0.01% | 3356 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
NAMA